Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$830M |
| 2 |
UnitedHealth
UNH
|
+$769M |
| 3 |
Arthur J. Gallagher & Co
AJG
|
+$691M |
| 4 |
Amazon
AMZN
|
+$654M |
| 5 |
Bank of America
BAC
|
+$634M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 2 |
NVIDIA
NVDA
|
+$550M |
| 3 |
Spotify
SPOT
|
+$473M |
| 4 |
Citigroup
C
|
+$460M |
| 5 |
Boston Scientific
BSX
|
+$428M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 3.13% |
| 2 | Technology | 2.97% |
| 3 | Financials | 2.19% |
| 4 | Consumer Discretionary | 2.09% |
| 5 | Industrials | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
13526
CALL
First Bancorp
FBP
$4.53B
| $11.2K | ﹤0.01% |
600
-1,800
| -75% | -$36.3K |
|
|
YSG
13527
PUT
Yatsen Holding
YSG
$319M
| $11.1K | ﹤0.01% |
2,800
+2,600
| +1,300% | +$10.7K |
|
|
ONL
13528
PUT
Orion Office REIT
ONL
$164M
| $11.1K | ﹤0.01% |
3,000
-3,200
| -52% | -$12.6K |
|
13529
PUT
Eledon Pharmaceuticals
ELDN
$273M
| $11.1K | ﹤0.01% |
+2,700
| New | +$10.6K |
|
13530
Splash Beverage Group
SBEV
$2.55M
| $11.1K | ﹤0.01% |
+432
| New | +$14.3K |
|
13531
CALL
Shore Bancshares
SHBI
$800M
| $11.1K | ﹤0.01% |
700
+500
| +250% | +$7.75K |
|
13532
PUT
NCR Voyix
VYX
$1.13B
| $11.1K | ﹤0.01% |
800
-13,400
| -94% | -$186K |
|
|
RGLS
13533
PUT
DELISTED
Regulus Therapeutics
RGLS
| $11.1K | ﹤0.01% |
7,000
-2,300
| -25% | -$3.53K |
|
13534
PUT
Innospec
IOSP
$2.31B
| $11K | ﹤0.01% |
100
-1,100
| -92% | -$126K |
|
13535
CALL
Acurx Pharmaceuticals
ACXP
$6.02M
| $11K | ﹤0.01% |
675
+215
| +47% | +$6.47K |
|
13536
PUT
iShares MSCI Singapore ETF
EWS
$1.17B
| $10.9K | ﹤0.01% |
+500
| New | +$11.1K |
|
13537
PUT
PDS Biotechnology
PDSB
$12.9M
| $10.9K | ﹤0.01% |
6,700
+600
| +10% | +$1.59K |
|
13538
CALL
SCYNEXIS
SCYX
$51.5M
| $10.9K | ﹤0.01% |
1,125
-163
| -13% | -$1.69K |
|
|
LLYX
13539
PUT
Defiance Daily Target 2x Long LLY ETF
LLYX
$44.8M
| $10.9K | ﹤0.01% |
+600
| New | +$13K |
|
|
NINE
13540
PUT
DELISTED
Nine Energy Service
NINE
| $10.9K | ﹤0.01% |
9,700
+1,900
| +24% | +$2.24K |
|
13541
Rekor Systems
REKR
$98.2M
| $10.9K | ﹤0.01% |
6,956
-662,263
| -99% | -$687K |
|
|
IMMP
13542
CALL
Immutep
IMMP
$56M
| $10.8K | ﹤0.01% |
5,000
-3,600
| -42% | -$7.23K |
|
13543
CALL
Caribou Biosciences
CRBU
$157M
| $10.8K | ﹤0.01% |
6,800
-36,000
| -84% | -$72.4K |
|
13544
PUT
Research Frontiers
REFR
$15.3M
| $10.8K | ﹤0.01% |
+6,300
| New | +$12.3K |
|
13545
CALL
Zedge
ZDGE
$38.4M
| $10.8K | ﹤0.01% |
4,000
+300
| +8% | +$873 |
|
13546
PUT
Televisa
TV
$1.53B
| $10.8K | ﹤0.01% |
6,400
-2,200
| -26% | -$4.77K |
|
|
SPNS
13547
PUT
DELISTED
Sapiens International
SPNS
| $10.7K | ﹤0.01% |
400
-600
| -60% | -$19.2K |
|
13548
PUT
Zegna
ZGN
$3.69B
| $10.7K | ﹤0.01% |
1,300
-100
| -7% | -$817 |
|
13549
PUT
IZEA Worldwide
IZEA
$53.8M
| $10.7K | ﹤0.01% |
+3,900
| New | +$10.5K |
|
13550
PUT
Nerdy
NRDY
$90.4M
| $10.7K | ﹤0.01% |
6,600
-17,800
| -73% | -$22.1K |
|
Similar funds
Ken Griffin's Q4 2024 Portfolio in Review
As of Q4 2024, Ken Griffin held 15,826 positions worth $578B, up 11% from $518B the previous quarter. Its ten largest holdings account for 31% of the portfolio.
Ken Griffin deployed $35.2B of net new capital in Q4 2024, opening 1,745 new positions and adding to 6,428 existing holdings. Its largest new stake was Zoetis: 1,090,499 shares worth $178M.
By sector, the portfolio is most concentrated in Healthcare at 3.1% of assets, up from 2.9% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.23B trimmed.
- Ken Griffin's largest Q4 2024 buy was Zoetis: 1,090,499 shares worth $178M.
- Ken Griffin added most to Boeing in Q4 2024, an estimated $830M increase.
- Ken Griffin's biggest Q4 2024 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.23B.
- Ken Griffin fully exited Spotify in Q4 2024, selling an estimated $473M.
- Ken Griffin's ten largest holdings make up 31% of its $578B portfolio in Q4 2024.
- Ken Griffin opened 1,745 new positions and closed 1,423 in Q4 2024.
- Ken Griffin's portfolio value rose 11% quarter-over-quarter to $578B.
Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.